Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/632857]Researchers: Prof Guy Marks (Principal investigator) , Prof John Seale , Prof Richard Menzies
Brief description Treatment of latent tuberculosis infection (LTBI) is one intervention that is known to prevent the occurrence of active TB. Current treatment is based on a six to nine month course of isoniazid. The treatment has side effects in some people and many people do not complete the treatment. The present study is to test an alternative treatment regimen (4 months of rifampicin) which has fewer side-effects and is more likely to be completed.
Funding Amount $AUD 496,875.13
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 632857
- PURL : https://purl.org/au-research/grants/nhmrc/632857
